Johnson & Johnson (NEO:JNJ)

Market Cap	653.89B
Revenue (ttm)	128.35B
Net Income (ttm)	34.99B
Shares Out	n/a
EPS (ttm)	14.41
PE Ratio	18.69
Forward PE	17.26
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,735
Average Volume	10,921
Open	25.17
Previous Close	24.94
Day's Range	25.09 - 25.19
52-Week Range	18.75 - 25.34
Beta	0.52
RSI	76.01
Earnings Date	Oct 14, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Cboe Canada
• Ticker Symbol: JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD